MarketInOut Stock Screener Log In | Sign Up

Sanofi S.A.

PAR • Healthcare • Drug Manufacturers - General • Quote as of 10/30/2026
Sanofi S.A. stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangePAR
Market Capitalization89,771 mln
Float1,092 mln
Earnings Date10/30/2026

EPS

3.23
Solid

P / E

24.69
Premium valuation

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.75
Likely reliable

1-Year Forecast

93.35
Attractive

Relative Strength

97 / 100
Top performer

Business Description

Sanofi is a Paris-based global pharmaceutical company founded in 1994 that researches, develops, manufactures, and sells treatments across a wide range of medical areas, including cancer, rare diseases, neurology, and inflammatory conditions. The company produces numerous vaccines covering illnesses such as influenza, polio, hepatitis, and rabies, among others. Sanofi works alongside a broad network of partners ? including Regeneron, Teva, and Denali Therapeutics ? to advance new therapies, from protein-based treatments and genome editing tools to AI-driven drug discovery platforms.

Key Fundamentals

EPS3.23
P/E24.69
ROE6.07
RPS40.50
ROIC8.39
ROA3.36
Interest Cover22.24
EBITDA, mln12,815
EV / EBITDA8.02
EV / EBIT17.14
Revenue, mln45,843
EV / Revenue2.24

Quote Details

Last 79.74
Change 3.59 (4.71%)
Open 79.25
Volume 5,450,081
Turnover 434,589,440
Average Volume 2,360,487

Financial Ratios

Pre-Tax Profit Margin12
Leverage Ratio1.86
Current Ratio0.99
Price / Book1.27
Price / Tangible Book70.52
Price / Cash Flow5.19
Price / Free Cash Flow8.61
Debt / Equity0.34
Price / Sales1.91
PEG Ratio29.31

Financial Strength

Altman Z-Score2.22
Piotroski F-Score 7 / 9
Beneish M-Score-2.75
Price to Intrinsic Value0.69
Price to Graham Number6.21
1-Year Target Price93.35
Shiller PE Ratio13.88

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.58% 95 / 100   
1 Month 9.08% 94 / 100   
2 Months 0.45% 61 / 100   
6 Months 8.14% 80 / 100   
1 Year -2.49% 39 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog